MECHANISMS OF CORTISOL-INDUCED HYPERTENSION IN HUMANS

被引:96
作者
WHITWORTH, JA [1 ]
BROWN, MA [1 ]
KELLY, JJ [1 ]
WILLIAMSON, PM [1 ]
机构
[1] UNIV NEW S WALES,ST GEORGE HOSP,DEPT RENAL MED,KOGARAH,NSW 2217,AUSTRALIA
基金
英国医学研究理事会;
关键词
GLUCOCORTICOID; SODIUM; VOLUME; SYMPATHETIC NERVOUS SYSTEM; INSULIN;
D O I
10.1016/0039-128X(94)00033-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is emerging evidence that cortisol plays a significantly greater role in human hypertension than previously thought. Apart from the well recognized role of cortisol in the hypertension of Cushing's syndrome, local cortisol excess has been recognized as responsible for rare forms of hypertension such as apparent mineralocorticoid excess and licorice abuse and more recently implicated in the hypertension of chronic renal failure, hypertension related to low birth weight and essential hypertension. Although cortisol-induced hypertension is characterized by sodium retention and volume expansion, studies with synthetic glucocorticoids or sodium restriction suggest that the hypertension is, to a substantial degree, independent of sodium and volume. Increase in cardiac output is not essential for cortisol-induced blood pressure rise but the precise role of increases in total or regional peripheral resistance as a primary mechanism has not been determined. Increased presser responsiveness, particularly to catechols, is a prominent feature but whether these changes are sufficient to account for the hypertension remains unclear. There is no evidence for increased sympathetic nervous activity as judged by measurements of plasma catcholamines, neuropeptide-Y, or resting noradrenaline spillover rate. Responses to mental stress or maximal hand-grip are unchanged and baroreflex sensitivity is increased. Octreotide profoundly reduced the elevated plasma insulin concentrations seen with cortisol administration but had no effect on the rise in blood pressure.
引用
收藏
页码:76 / 80
页数:5
相关论文
共 33 条
[1]  
AXELROD L, 1983, LANCET, V1, P904
[2]  
CARETTA R, 1989, J HYPERTENS S6, V7, pS196
[3]  
CONNELL JMC, 1987, J HYPERTENS, V5, P425
[4]  
CONNELL JMC, 1988, J HYPERTENS, V6, P17
[5]   DYSFUNCTION OF PLACENTAL GLUCOCORTICOID BARRIER - LINK BETWEEN FETAL ENVIRONMENT AND ADULT HYPERTENSION [J].
EDWARDS, CRW ;
BENEDIKTSSON, R ;
LINDSAY, RS ;
SECKL, JR .
LANCET, 1993, 341 (8841) :355-357
[6]   GUSTATORY THRESHOLDS IN PATIENTS WITH HYPERTENSION [J].
FALLIS, N ;
TETREAULT, L ;
LASAGNA, L .
NATURE, 1962, 196 (4849) :74-&
[7]   DEVELOPMENT OF HYPERTENSION IN ANIMALS WITH REDUCED TOTAL PERIPHERAL RESISTANCE [J].
HUANG, M ;
HESTER, RL ;
COLEMAN, TG ;
SMITH, MJ ;
GUYTON, AC .
HYPERTENSION, 1992, 20 (06) :828-833
[8]   ELECTROLYTES IN HYPERTENSION - EFFECTS OF SODIUM CHLORIDE - EVIDENCE FROM ANIMAL AND HUMAN STUDIES [J].
MENEELY, GR ;
DAHL, LK .
MEDICAL CLINICS OF NORTH AMERICA, 1961, 45 (02) :271-&
[9]   METABOLIC AND BLOOD-PRESSURE RESPONSES TO HYDROCORTISONE IN THE SYNDROME OF APPARENT MINERALOCORTICOID EXCESS [J].
OBERFIELD, SE ;
LEVINE, LS ;
CAREY, RM ;
GREIG, F ;
ULICK, S ;
NEW, MI .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (02) :332-339
[10]   HYDROCORTISONE-INDUCED HYPERTENSION IN MEN - THE ROLE OF CARDIAC-OUTPUT [J].
PIRPIRIS, M ;
YEUNG, S ;
DEWAR, E ;
JENNINGS, GL ;
WHITWORTH, JA .
AMERICAN JOURNAL OF HYPERTENSION, 1993, 6 (04) :287-294